The perfluorocarbon fluoromethyloadamantane offers cerebral protection in a model of isovolemic hemodilution in rabbits

Stroke

Volumn 25, Issue 1, 1994, Pages 197-201

  Sakas, Damianos E ^a   Crowell, Robert M ^a   Kim, Kwantae ^a   Korosue, Kasuyoshi ^a   Zervas, Nicholas T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cerebral infarction; Cerebral ischemia; Hemodilution; Perfluorocarbons

Indexed keywords

DEXTRAN 40; FLUOROCARBON; PERFLUOROMETHYLADAMANTANE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN METABOLISM; BRAIN PROTECTION; BRAIN TEMPERATURE; CONTROLLED STUDY; EXPERIMENTAL MODEL; FEMALE; HEMATOCRIT; HEMODILUTION; HEMODYNAMIC PARAMETERS; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ADAMANTANE; ANIMAL; BRAIN; BRAIN ISCHEMIA; CEREBRAL INFARCTION; COMPARATIVE STUDY; DEXTRANS; FEMALE; HEMODILUTION; MALE; OXYGEN; RABBITS; SUPPORT, NON-U.S. GOV'T;

EID: 0028057988     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/01.STR.25.1.197     Document Type: Article

References (33)

1. Crowell RM, Olsson Y. Impaired microvascular filling after focal cerebral ischemia in the monkey: modification by treatment. Neurology. 1974;22:500-504.
2. Heros RC, Korosue K. Hemodilution for cerebral ischemia. Stroke. 1989;20:423-427.
3. Sundt TM, Waltz AG, Sayre GP. Experimental cerebral infarction: modification by treatment with hemodiluting, hemoconcentrating and dehydrating agents. J Neurosurg. 1967;26:46-56.
4. Wood JH, Simeone FA, Fink EA, Golden MA. Correlative aspects of hypervolemic hemodilution: low-molecular-weight dextran infusions after experimental cerebral arterial occlusion. Neurology. 1984;34:24-34.
5. Brown MM, Wade JPH, Marchall J. Fundamental importance of arterial oxygen content in the regulation of cerebral blood flow in man. Brain. 1985;108:81-93.
6. Czer LSC, Shoemaker WC. Optimal hematocrit value in critically ill postoperative patients. Surg Gynecol Obstet. 1978;147:363-368.
7. Clark LC Jr, Golan F. Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science. 1966;152:1755-1756.
8. Geyer RP. Perfluorochemicals as oxygen transport vehicles. Biomater Artif Cells Artif Organs. 1988;16:31-49.
9. Sloviter HA, Kaminoto T. Erythrocyte substitute for perfusion of brain. Nature. 1967;216:458-460.
10. Tu YK, Heros RC, Karacostas D, Liszczak T, Hyodo A, Candia G, Zervas NT, Lagree K. Isovolemic hemodilution in experimental focal cerebral ischemia, part II: effects on regional cerebral blood flow and size of infarction. J Neurosurg. 1988;69:82-91.
11. Korosue K, Heros RC, Ogilvy CS, Hyodo A, Tu YK, Graichen R. Comparison of crystalloids and colloids for hemodilution in a model of focal cerebral ischemia. J Neurosurg. 1990;73:576-584.
12. Mast H, Marx P. Neurological deterioration under isovolemic hemodilution with hydroxyethyl starch in acute cerebral ischemia. Stroke. 1991;22:680-683.
13. Kolluri S, Heros RC, Hedley-Whyte ET, Vonsatell JP, Miller D, Zervas NT. Comparison of the effect of Fluosol DA and dextran 40 on regional cerebral blood flow, infarction size, and mortality in cats with temporary occlusion of the middle cerebral artery. Surg Neurol, 1986;26:3-8.
14. Menzies SA, Hoff JT, Betz AL. Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model. Neurosurg. 1992;31:100-107.
15. Kolluri S, Heros RC, Hedley-Whyte ET, Vonsatell JP, Miller D, Zervas NT. Effect of Fluosol on oxygen availability, regional cerebral blood flow, and infarct size in a model of temporary focal cerebral ischemia. Stroke. 1986;17:976-980.
16. Han DH, Zervas NT, Geyer RP, Adams JF, Ropper AH, Kennedy SK, Heros RC, Varsos VG, Borges L, Hedley-Whyte ET. Can perfluorochemicals reduce cerebral ischemia? In: Reivich M, Hurtig HI, eds. Cerebrovascular Diseases. New York, NY: Raven Press, Publishers; 1983:409-419.
17. Fuhrman BP, Paczan PR, DeFrancisis M. Perfluorocarbonassociated gas exchange. Crit Care Med. 1991;19:712-722.
18. Goldsmith MM, Palladino GW, Proctor HJ. Cerebral cortical ATP and lactate concentrations after exchange transfusion with Fluosol (F-43). Surg Forum. 1981;32:16-19.
19. Lee PA, McHale PA, Piantadosi CA, Sylvia AL. Regional cerebral blood flow in normal blood circulated and perfluorocarbon perfused rats. Adv Exp Med Biol. 1986;200:59-65.
20. Kontos HA, Wei EP, Raper AJ, Rosenblum WI, Navari RM, Patterson JL Jr. Role of tissue hypoxia in local regulation of cerebral microcirculation. Am J Physiol. 1978;234:H582-H591.
21. Bose B, Osterholm JL, Triolo AJ. Focal cerebral ischemia: reduction in size of infarcts by ventriculosubarachnoid perfusion with fluorocarbon emulsion. Brain Res. 1985;328:223-231.
22. Osterholm JL, Alderman JB, Triolo AJ, D’Amore BR, Williams HD, Frazer G. Severe cerebral ischemia treatment by ventriculosubarachnoid perfusion with an oxygenated fluorocarbon emulsion. Neurosurgery. 1983;13:381-387.
23. Nagasawa S, Handa H, Naruo Y. Effects of transfusion with a blood substitute (Fluosol DA, 20%) in the monkey. Neurol Res. 1981;3:237-250.
24. Memezawa H, Katayama Y, Shimizu J, Suzuki S, Kashiwagi F, Kamiya T, Terashi A. Effects of Fluosol-DA on brain edema, energy metabolites, and tissue oxygen content in acute cerebral ischemia. Adv Neurol. 1990;52:109-118.
25. Peerless SJ, Ishikawa R, Hunter 1G, Peerless MJ. Protective effect of Fluosol-DA in acute cerebral ischemia. Stroke. 1981;12:558-563.
26. Sutherland GR, Farrar JK, Peerless SJ. The effect of Fluosol-DA on oxygen availability in focal cerebral ischemia. Stroke. 1984;15:829-835.
27. Peerless SJ, Nakamura R, Rodriguez-Salazar A, Hunter IG. Modification of cerebral ischemia with Fluosol. Stroke. 1985;16:38-43.
28. Handa H, Nagasawa S, Yonekawa Y. New treatment of cerebral vasospasm with Fluosol-DA 20%: protective effect on cerebral ischemia and change of cerebral blood flow. In: Bolin B, ed. Advances in Blood Substitute Research. New York, NY: Alan R Liss, Inc; 1983:299-306.
29. Triolo AJ, Osterholm JL, Kratky MT. Enhancement of the Arthus reaction and suppression of delayed type hypersensitivity (DTH) by pluronic F-68, a detergent frequently used to prepare perfluorocarbon emulsions. Int J Immunopharmacol. 1989;11:241-248.
30. Carr ME Jr, Powers PL, Jones MR. Effects of poloxamer 188 on the assembly, structure and dissolution of fibrin clots. Thromb Haemost. 1991;66:565-568.
31. Lane TA, Krukonis V. Reduction of the toxicity of an artificial blood substitute by supercritical fluid fractionation. Transfusion. 1988;28:375-378.
32. Williams JH Jr, Chen M, Drew J, Panigan E, Hosseini S. Modulation of rat granulocyte traffic by a surface active agent in vitro and bleomycin injury. Proc Soc Exp Biol Med. 1988;188:461-470.
33. Vercellotti GM, Hammerschmidt DE, Craddock PR, Jacob HS. Activation of plasma complement by perfluorocarbon artificial blood: probable mechanism of adverse pulmonary reactions in treated patients and rationale for corticosteroid prophylaxis. Blood. 1982;59:1299-1304.